Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nao'an capsule is a traditional Chinese patent medicine primarily used for the treatment and primary prevention of ischemic stroke. It is formulated from five herbal ingredients: Chuanxiong (*Ligusticum chuanxiong*), Danggui (*Angelica sinensis*), Honghua (*Carthamus tinctorius*), Ginseng (*Panax ginseng*), and Borneol. The capsule is designed to promote blood circulation, resolve blood stasis, and benefit qi to dredge the collaterals. It is developed by Longhua Hospital, Shanghai University of Traditional Chinese Medicine, and manufactured by companies such as Anhui Leiyunshang Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nao'an capsule.